Literature DB >> 27135648

Vacuolin-1 inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibition.

Osamu Sano1, Kenichi Kazetani1, Masaaki Funata1, Yasunori Fukuda1, Junji Matsui1, Hidehisa Iwata1.   

Abstract

Lysosomal protein degradation via autophagy strictly regulates cellular protein homoeostasis. Herein we performed high-content screening to identify compounds that inhibit autophagy pathways. We obtained 11 hit compounds and performed cluster analysis using cellular morphological information. Vacuolin-1, which induces the formation of giant vacuoles and is a target unknown compound, clustered with the known PIKfyve inhibitor YM201636. We further confirmed that vacuolin-1 is a potent PIKfyve inhibitor, and we finally concluded that PIKfyve inhibitors are novel chemical tools for regulating autophagy.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  PIKfyve; autophagy; vacuolin-1

Mesh:

Substances:

Year:  2016        PMID: 27135648     DOI: 10.1002/1873-3468.12195

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis.

Authors:  Gaurav Sharma; Carlos M Guardia; Ajit Roy; Alex Vassilev; Amra Saric; Lori N Griner; Juan Marugan; Marc Ferrer; Juan S Bonifacino; Melvin L DePamphilis
Journal:  Autophagy       Date:  2019-03-08       Impact factor: 16.016

2.  PIKfyve Deficiency in Myeloid Cells Impairs Lysosomal Homeostasis in Macrophages and Promotes Systemic Inflammation in Mice.

Authors:  Sang Hee Min; Aae Suzuki; Lehn Weaver; Jessica Guzman; Yutein Chung; Huiyan Jin; Francina Gonzalez; Claire Trasorras; Liang Zhao; Lynn A Spruce; Steven H Seeholzer; Edward M Behrens; Charles S Abrams
Journal:  Mol Cell Biol       Date:  2019-10-11       Impact factor: 4.272

3.  Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.

Authors:  Sophia Gayle; Sean Landrette; Neil Beeharry; Chris Conrad; Marylens Hernandez; Paul Beckett; Shawn M Ferguson; Talya Mandelkern; Meiling Zheng; Tian Xu; Jonathan Rothberg; Henri Lichenstein
Journal:  Blood       Date:  2017-01-19       Impact factor: 22.113

Review 4.  Into the eyes of bone marrow-derived mesenchymal stem cells therapy for myocardial infarction and other diseases.

Authors:  Jian-Rui Li; Ting-Ting Qu
Journal:  Stem Cell Investig       Date:  2017-08-23

Review 5.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

Review 6.  From Pinocytosis to Methuosis-Fluid Consumption as a Risk Factor for Cell Death.

Authors:  Markus Ritter; Nikolaus Bresgen; Hubert H Kerschbaum
Journal:  Front Cell Dev Biol       Date:  2021-06-23

7.  Combined Inhibition of p38MAPK and PIKfyve Synergistically Disrupts Autophagy to Selectively Target Cancer Cells.

Authors:  Constandina E O'Connell; Alex Vassilev
Journal:  Cancer Res       Date:  2021-03-08       Impact factor: 13.312

8.  Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.

Authors:  Lois S Weisman; Juan Botas; Ismael Al-Ramahi; Sai Srinivas Panapakkam Giridharan; Yu-Chi Chen; Samarjit Patnaik; Nathaniel Safren; Junya Hasegawa; Maria de Haro; Amanda K Wagner Gee; Steven A Titus; Hyunkyung Jeong; Jonathan Clarke; Dimitri Krainc; Wei Zheng; Robin F Irvine; Sami Barmada; Marc Ferrer; Noel Southall; Juan Jose Marugan
Journal:  Elife       Date:  2017-12-26       Impact factor: 8.140

9.  Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition.

Authors:  Akito Ono; Osamu Sano; Ken-Ichi Kazetani; Takamichi Muraki; Keisuke Imamura; Hiroyuki Sumi; Junji Matsui; Hidehisa Iwata
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

10.  Using a biologically annotated library to analyze the anticancer mechanism of serine palmitoyl transferase (SPT) inhibitors.

Authors:  Osamu Sano; Ken-Ichi Kazetani; Ryutaro Adachi; Osamu Kurasawa; Tomohiro Kawamoto; Hidehisa Iwata
Journal:  FEBS Open Bio       Date:  2017-02-13       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.